A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Test Product; Drug: Reference Product Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2019 Category: Research Source Type: clinical trials
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Condition: Asthma Interventions: Drug: Fluticasone Propionate and Salmeterol Inhalation Powder; Drug: Placebo Inhalation Powder Sponsors: Actavis Inc.; Teva Pharmaceuticals USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials
A Non-interventional Salmeterol/Fluticasone Easyhaler Study
Conditions: Asthma; Chronic Obstructive Pulmonary Disease Intervention: Sponsor: Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Condition: Asthma Interventions: Drug: Fluticasone Propionate and Salmeterol Inhalation Powder; Drug: Placebo Inhalation Powder Sponsors: Actavis Inc.; Teva Pharmaceuticals USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials
A Non-interventional Salmeterol/Fluticasone Easyhaler Study
Conditions: Asthma; Chronic Obstructive Pulmonary Disease Intervention: Sponsor: Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials
